Jaguar Gene Therapy

📍 Lake Forest, United States🗓 Founded 2019👥 72 employees💰 Last funded Mar 2022
Biotechnology Research🌐 jaguargenetherapy.com
Website LinkedIn
Jaguar Gene Therapy, LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases including those that impact sizeable patient populations. The company is made up of a proven team of experts with unparalleled CMC (Chemistry, Manufacturing and Controls), regulatory, clinical and commercial acumen who have first-hand experience in bringing novel gene therapy treatments to patients and their families. Committed to patient safety and product purity, Jaguar is rapidly advancing an initial pipeline of three programs targeting: 1) Type 1 galactosemia; 2) a genetic cause of autism spectrum disorder and Phelan-McDermid syndrome and other severe neurodevelopmental disorders with a SHANK3 mutation or deletion; and 3) Type 1 diabetes. The company continues to evaluate opportunities to expand its pipeline using the strength of the team and close relationships with numerous academic institutions.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Jaguar Gene Therapy?
Jaguar Gene Therapy has 1 investors on record on gritt.io, 1 mid-stage.
When did Jaguar Gene Therapy last raise funding?
The most recent investment in Jaguar Gene Therapy recorded on gritt.io was in March 2022.
When was Jaguar Gene Therapy founded?
Jaguar Gene Therapy was founded in 2019.
What industry is Jaguar Gene Therapy in?
Jaguar Gene Therapy operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Jaguar Gene Therapy based?
Jaguar Gene Therapy is headquartered in Lake Forest, United States.